Maxim’s healthcare analyst Jason Kolbert reiterated coverage on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and cell therapy company Cytori Therapeutics Inc (NASDAQ:CYTX).
In a research report released today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), while introducing a new …
Maxim’s healthcare analyst Jason Kolbert weighted in today on the clinical-stage biopharmaceutical company Anavex Life Sciences Corp. (NASDAQ:AVXL) and stem cell research company StemCells Inc (NASDAQ:STEM).
In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with …
Maxim Group analyst Jason Kolbert came out today with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company announced that the independent Data and Safety …
Maxim’s healthcare analyst Jason Kolbert weighed in today with an optimistic view on OncoSec Medical Inc (NASDAQ:ONCS), after the company announced positive results from a …
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a …
Maxim’s healthcare analyst Jason Kolbert came out with a positive commentary on TrovaGene Inc (NASDAQ:TROV), following the news that the company’s urine-based HPV HR Test is equally capable of detecting …
Maxim’s healthcare analyst Jason Kolbert came out today with his views on IsoRay, Inc (NYSEMKT:ISR), after the company released its financial results for the quarter ended June …
In a research report released Wednesday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an $8 price …
